Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore.

Translated title of the contribution: Sufentanil vs morphine combined with ropivacaine for thoracic epidural analgesia in major abdominal surgery

P. Gianferrari, M. E. Clara, B. Borghi, A. Marzullo, M. Voltolina, P. De Paolis, N. Montone

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Pain, postoperative ileus, nausea, vomiting are the universal complications after major abdominal surgery. The aim of this study was to assess pain relief, side effects and recovery of gastrointestinal function during epidural analgesia with ropivacaine plus sufentanil and ropivacaine plus morphine after major abdominal surgery. METHODS: In this prospective study, sixty patients (median age 62+/-12 years) undergoing major abdominal surgery, after informed consent, were randomized into two groups, during a period of 3 months. Patients who were not considered suitable candidates for epidural anaesthesia were excluded. Epidural catheters were inserted at T8-T9 (upper abdominal surgery) or T9-T11 (lower abdominal surgery) and ropivacaine 0,5% 7-9 ml (upper abdominal surgery) or 10-12 ml (lower abdominal surgery) combined with sufentanil 30 mcg (group S, n=30) or with morphine 2 mg (group M, n=30) was injected. General anaesthesia was induced and a continuous epidural infusion of ropivacaine 0.5% 5-10 ml/h was begun. Postoperatively, continuous epidural administration of ropivacaine 0.2% plus sufentanil 0.5 mcg/ml (group S) or ropivacaine 0.2 plus morphine 0.02 mg/ml (group M) was continued. Data on the quality of analgesia, recovery of gastrointestinal function and all side effects were recorded for 48 hours. RESULTS: Incident and resting pain scores were not significantly different among group; although sufentanil provided better resting pain scores at 16th, 20th, 24th hours, and incident pain score at 24th hour. The incidence of nausea, vomiting and pruritus was more in morphine group (p

Original languageItalian
Pages (from-to)155-159
Number of pages5
JournalMinerva Anestesiologica
Volume67
Issue number9 Suppl 1
Publication statusPublished - Sep 2001

Fingerprint

Sufentanil
Epidural Analgesia
Morphine
Thorax
Pain
Recovery of Function
Postoperative Nausea and Vomiting
Ileus
Epidural Anesthesia
Pruritus
ropivacaine
Informed Consent
Analgesia
General Anesthesia
Nausea
Vomiting
Catheters
Prospective Studies
Incidence

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Gianferrari, P., Clara, M. E., Borghi, B., Marzullo, A., Voltolina, M., De Paolis, P., & Montone, N. (2001). Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore. Minerva Anestesiologica, 67(9 Suppl 1), 155-159.

Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore. / Gianferrari, P.; Clara, M. E.; Borghi, B.; Marzullo, A.; Voltolina, M.; De Paolis, P.; Montone, N.

In: Minerva Anestesiologica, Vol. 67, No. 9 Suppl 1, 09.2001, p. 155-159.

Research output: Contribution to journalArticle

Gianferrari, P, Clara, ME, Borghi, B, Marzullo, A, Voltolina, M, De Paolis, P & Montone, N 2001, 'Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore.', Minerva Anestesiologica, vol. 67, no. 9 Suppl 1, pp. 155-159.
Gianferrari, P. ; Clara, M. E. ; Borghi, B. ; Marzullo, A. ; Voltolina, M. ; De Paolis, P. ; Montone, N. / Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore. In: Minerva Anestesiologica. 2001 ; Vol. 67, No. 9 Suppl 1. pp. 155-159.
@article{f97594bed10e4c7299563882f938434b,
title = "Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore.",
abstract = "BACKGROUND: Pain, postoperative ileus, nausea, vomiting are the universal complications after major abdominal surgery. The aim of this study was to assess pain relief, side effects and recovery of gastrointestinal function during epidural analgesia with ropivacaine plus sufentanil and ropivacaine plus morphine after major abdominal surgery. METHODS: In this prospective study, sixty patients (median age 62+/-12 years) undergoing major abdominal surgery, after informed consent, were randomized into two groups, during a period of 3 months. Patients who were not considered suitable candidates for epidural anaesthesia were excluded. Epidural catheters were inserted at T8-T9 (upper abdominal surgery) or T9-T11 (lower abdominal surgery) and ropivacaine 0,5{\%} 7-9 ml (upper abdominal surgery) or 10-12 ml (lower abdominal surgery) combined with sufentanil 30 mcg (group S, n=30) or with morphine 2 mg (group M, n=30) was injected. General anaesthesia was induced and a continuous epidural infusion of ropivacaine 0.5{\%} 5-10 ml/h was begun. Postoperatively, continuous epidural administration of ropivacaine 0.2{\%} plus sufentanil 0.5 mcg/ml (group S) or ropivacaine 0.2 plus morphine 0.02 mg/ml (group M) was continued. Data on the quality of analgesia, recovery of gastrointestinal function and all side effects were recorded for 48 hours. RESULTS: Incident and resting pain scores were not significantly different among group; although sufentanil provided better resting pain scores at 16th, 20th, 24th hours, and incident pain score at 24th hour. The incidence of nausea, vomiting and pruritus was more in morphine group (p",
author = "P. Gianferrari and Clara, {M. E.} and B. Borghi and A. Marzullo and M. Voltolina and {De Paolis}, P. and N. Montone",
year = "2001",
month = "9",
language = "Italian",
volume = "67",
pages = "155--159",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "9 Suppl 1",

}

TY - JOUR

T1 - Sufentanil vs morgina in associazione alla ropivacaina per l'analgesia epidurale toracica in chirurgia addominale maggiore.

AU - Gianferrari, P.

AU - Clara, M. E.

AU - Borghi, B.

AU - Marzullo, A.

AU - Voltolina, M.

AU - De Paolis, P.

AU - Montone, N.

PY - 2001/9

Y1 - 2001/9

N2 - BACKGROUND: Pain, postoperative ileus, nausea, vomiting are the universal complications after major abdominal surgery. The aim of this study was to assess pain relief, side effects and recovery of gastrointestinal function during epidural analgesia with ropivacaine plus sufentanil and ropivacaine plus morphine after major abdominal surgery. METHODS: In this prospective study, sixty patients (median age 62+/-12 years) undergoing major abdominal surgery, after informed consent, were randomized into two groups, during a period of 3 months. Patients who were not considered suitable candidates for epidural anaesthesia were excluded. Epidural catheters were inserted at T8-T9 (upper abdominal surgery) or T9-T11 (lower abdominal surgery) and ropivacaine 0,5% 7-9 ml (upper abdominal surgery) or 10-12 ml (lower abdominal surgery) combined with sufentanil 30 mcg (group S, n=30) or with morphine 2 mg (group M, n=30) was injected. General anaesthesia was induced and a continuous epidural infusion of ropivacaine 0.5% 5-10 ml/h was begun. Postoperatively, continuous epidural administration of ropivacaine 0.2% plus sufentanil 0.5 mcg/ml (group S) or ropivacaine 0.2 plus morphine 0.02 mg/ml (group M) was continued. Data on the quality of analgesia, recovery of gastrointestinal function and all side effects were recorded for 48 hours. RESULTS: Incident and resting pain scores were not significantly different among group; although sufentanil provided better resting pain scores at 16th, 20th, 24th hours, and incident pain score at 24th hour. The incidence of nausea, vomiting and pruritus was more in morphine group (p

AB - BACKGROUND: Pain, postoperative ileus, nausea, vomiting are the universal complications after major abdominal surgery. The aim of this study was to assess pain relief, side effects and recovery of gastrointestinal function during epidural analgesia with ropivacaine plus sufentanil and ropivacaine plus morphine after major abdominal surgery. METHODS: In this prospective study, sixty patients (median age 62+/-12 years) undergoing major abdominal surgery, after informed consent, were randomized into two groups, during a period of 3 months. Patients who were not considered suitable candidates for epidural anaesthesia were excluded. Epidural catheters were inserted at T8-T9 (upper abdominal surgery) or T9-T11 (lower abdominal surgery) and ropivacaine 0,5% 7-9 ml (upper abdominal surgery) or 10-12 ml (lower abdominal surgery) combined with sufentanil 30 mcg (group S, n=30) or with morphine 2 mg (group M, n=30) was injected. General anaesthesia was induced and a continuous epidural infusion of ropivacaine 0.5% 5-10 ml/h was begun. Postoperatively, continuous epidural administration of ropivacaine 0.2% plus sufentanil 0.5 mcg/ml (group S) or ropivacaine 0.2 plus morphine 0.02 mg/ml (group M) was continued. Data on the quality of analgesia, recovery of gastrointestinal function and all side effects were recorded for 48 hours. RESULTS: Incident and resting pain scores were not significantly different among group; although sufentanil provided better resting pain scores at 16th, 20th, 24th hours, and incident pain score at 24th hour. The incidence of nausea, vomiting and pruritus was more in morphine group (p

UR - http://www.scopus.com/inward/record.url?scp=0035469068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035469068&partnerID=8YFLogxK

M3 - Articolo

C2 - 11778111

AN - SCOPUS:0035469068

VL - 67

SP - 155

EP - 159

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 9 Suppl 1

ER -